MERIT MEDICAL SYSTEMS INC (MMSI) earnings date

Nasdaq · Mid cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 30 days, typically, give or take 12 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Oct 29, 2026after close 29 8-K
Q2 FY2026Thu, Jul 30, 2026after close 30 8-K
Q1 FY2026Thu, Apr 30, 2026after close 30 8-K
Q4 FY2025Tue, Feb 24, 2026after close 55 8-K
Q3 FY2025Thu, Oct 30, 2025after close 30 8-K
Q2 FY2025Wed, Jul 30, 2025after close 30 8-K
Q1 FY2025Thu, Apr 24, 2025after close 24 8-K
Q4 FY2024Tue, Feb 25, 2025after close 56 8-K

What they guided beta

Q3 FY2026 "EX-99.1 2 mmsi-ex99d1.htm EX-99.1 Exhibit 99.1 ​ ​ ​ ​ ​ ​ ​ ​ Contacts: ​ ​ ​ ​ PR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare ​ ​ +1-801-432-2864 +1-443-213-0509 ​ ​ sarah.comstock@merit.com mike.piccinino@icrhealthcare.com ​ ​ ​ ​ ​ ​ FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS THIRD QUARTER 2026 RESULTS: DELIVERS 9% ORGANIC CONSTANT CURRENCY REVENUE GROWTH AND RAISES FULL-YEAR 2026 GUIDANCE Financial Highlights†" exhibit
Q3 FY2026 "Aronson 1 continued: “We have raised our 2026 revenue and non-GAAP earnings per share guidance to reflect the stronger-than-expected results over the first nine months of 2026 and remain confident in our team’s ability to execute, with attractive constant currency growth, improving profitability, and solid cash flow generation this year." exhibit
Q3 FY2026 "Fiscal Year 2026 Financial Guidance Based upon the information currently available to Merit’s management, for the twelve-month period ending December 31, 2026, absent the potential impact of trade policies and related actions implemented by the U.S. and other countries subsequent to today’s date, material acquisitions, non-recurring transactions or other factors beyond Merit’s current expectations, Merit anticipates the following financial results: ​ Revenue and Earnings Guidance* ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Updated Guidance Prior Guidance (2) ​ ​ Year Ending % Change Year Ending % Change Financial Me" exhibit
Q3 FY2026 "(2) “Prior Guidance” reflects Merit’s full-year 2026 financial guidance, previously introduced on July 30, 2026." exhibit
Q3 FY2026 "Merit’s financial guidance for the year ending December 31, 2026 is subject to risks and uncertainties identified in this release and Merit’s filings with the SEC." exhibit
Q2 FY2026 "EX-99.1 2 mmsi-20260730xex99d1.htm EX-99.1 Exhibit 99.1 ​ ​ ​ ​ ​ ​ ​ ​ Contacts: ​ ​ ​ ​ PR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare ​ ​ +1-801-432-2864 +1-443-213-0509 ​ ​ sarah.comstock@merit.com mike.piccinino@icrhealthcare.com ​ ​ ​ ​ ​ ​ FOR IMMEDIATE RELEASE MERIT MEDICAL REPORTS SECOND QUARTER 2026 RESULTS AND UPDATES FULL-YEAR 2026 GUIDANCE Financial Highlights†" exhibit
Q2 FY2026 "“We experienced improving revenue growth trends across our global business in Q2, as expected, with notable strength in sales to customers in the U.S. which increased 10% year-over-year, well ahead of our expectations." exhibit
Q2 FY2026 "Aronson continued: “We have increased our 2026 revenue and non-GAAP earnings per share guidance to reflect the stronger-than-expected results over the first half of 2026 and remain confident in our team’s ability to execute, with attractive constant currency growth, improving profitability, and solid cash flow generation this year." exhibit
Q2 FY2026 "Fiscal Year 2026 Financial Guidance Based upon the information currently available to Merit’s management, for the twelve-month period ending December 31, 2026, absent the potential impact of trade policies and related actions implemented by the U.S. and other countries subsequent to today’s date, material acquisitions, non-recurring transactions or other factors beyond Merit’s current expectations, Merit anticipates the following financial results: ​ Revenue and Earnings Guidance* ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Updated Guidance Prior Guidance (2) ​ ​ Year Ending % Change Year Ending % Change Financial Me" exhibit
Q2 FY2026 "(2) “Prior Guidance” reflects Merit’s full-year 2026 financial guidance, previously introduced on April 30, 2026." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/MMSI
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/MMSI

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

MMSI earnings date badge

HTML

<a href="https://veritasdata.dev/company/MMSI/"><img src="https://veritasdata.dev/embed/MMSI.svg" alt="MMSI earnings date" width="240" height="56"></a>

Markdown

[![MMSI earnings date](https://veritasdata.dev/embed/MMSI.svg)](https://veritasdata.dev/company/MMSI/)

Script

<script async src="https://veritasdata.dev/embed/MMSI.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/MMSI"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.